Principal Scientist, TechBio Discovery

Recursion•New York, NY

11h•Hybrid

About The Position

Recursion is at the forefront of reimagining drug discovery by integrating technological innovations across biology, chemistry, automation, data science, and engineering to radically improve lives by industrializing drug discovery. We are seeking an experienced Associate Director to join our Discovery Biology team to lead and advance our AI-driven portfolio of therapeutic candidates. This is a truly unique opportunity to work at the dynamic intersection of technology and biology. You won't just manage projects and key initiatives; you will be an active catalyst contributing to the evolution of a new, powerful paradigm in medicine.

Requirements

PhD in a relevant biological science discipline (e.g., Molecular Biology, Oncology, Pharmacology, Biochemistry, Computational Biology) with at least 7+ years of experience in Tech-forward Biotech or Pharma
A proven track record of accomplishments in drug discovery, with specific experience in operating as a Scientific Team Lead for oncology and/or immuno-oncology programs from early discovery to a clinical candidate stage
Demonstrated experience with modern drug discovery approaches, including familiarity with AI/ML-driven platforms and models, high-throughput screening, ‘omics data analysis, with a systems biology mindset.
Strong understanding of the oncology landscape, including key therapeutic modalities, emerging targets, and clinical development challenges.
Exceptional leadership and interpersonal skills, with the ability to lead and motivate high-performing, cross-functional teams in a fast-paced, matrix environment.
Demonstrated ability to deliver impactful, clear presentations and memos to a wide range of audiences, including the Executive Leadership Team (ELT), program teams, Key Opinion Leaders (KOLs), and external partners.
A strategic and tactical thinker who can prioritize competing demands and solve complex problems with a solution-focused mindset.

Responsibilities

Play a critical role in defining and executing our oncology strategy, seamlessly integrating traditional drug discovery principles with cutting-edge in silico computational approaches.
Lead scientific initiatives focused on successfully delivering various small molecule programs from initial hit to candidate selection and IND submission.
Contribute to novel target insight generation, patient refinement and patient selection strategies within several early discovery programs and have the opportunity to improve the Recursion OS itself.